Collateral Therapeutics

Business Data, Corporate Office and Headquarter Address

About

Collateral Therapeutics is Clinics/Outpatient Services in United States that focus on myocardial adrenergic signaling business. Founded in 1995. They cover business area such as Provider, cardio-vascular gene therapy method, angio-genesis, myocardial adrenergic signaling and heart muscle regeneration, proprietary technology, cardiovascular disease.

Business Type

Clinics/Outpatient Services

Country

United States

Founded

1995
( 29 years old in 2024 )

Company Focus

Myocardial Adrenergic Signaling

Website

-

Corporate Office and Headquarter Office address:

11622 El Camino Real
San Diego, CA 92130
United States

Phone number:

Private

Office Opening Hours*:

Monday 9.30 - 17.00
Tuesday 9.30 - 17.00
Wednesday 9.30 - 17.00
Thursday 9.30 - 17.00
Friday 9.30 - 17.00
Saturday Closed
Sunday Closed

Business Coverage

Providercardio-vascular gene therapy methodangio-genesismyocardial adrenergic signaling and heart muscle regenerationproprietary technologycardiovascular disease

* We use standard office opening hours in near Collateral Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.

Collateral Therapeutics Frequently Asked Questions

What or who is Collateral Therapeutics?

Collateral Therapeutics is Clinics/Outpatient Services business from United States that founded in 1995 (29 years old in 2024), Collateral Therapeutics business is focusing on Myocardial Adrenergic Signaling.

Where is Collateral Therapeutics headquarter and corporate office address?

Collateral Therapeutics headquarter office and corporate office address is located in 11622 El Camino Real San Diego, CA 92130 United States.

Where is Collateral Therapeutics country origins?

Collateral Therapeutics was founded in United States.

What is Myocardial Adrenergic Signaling business focus on?

In 2024, Collateral Therapeutics is currently focus on myocardial adrenergic signaling sector.

Myocardial Adrenergic Signaling Business Interest from Google Trend

Above is snippet of Google Trends for "myocardial adrenergic signaling" term, if you have problem loading the snippet, please visit here: Google Trend.

Disclaimer: This website is not affiliated with Collateral Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.